Literature DB >> 9598998

Protection against apoptosis by monoamine oxidase A inhibitors.

W Malorni1, A M Giammarioli, P Matarrese, P Pietrangeli, E Agostinelli, A Ciaccio, E Grassilli, B Mondovi.   

Abstract

Several lines of evidence have been accumulating indicating that an important role may be played by mitochondrial homeostasis in the initiation phase, the first stage of apoptosis. This work describes the results obtained by using different inhibitors of monoamine oxidases (MAO), i.e. pargyline, clorgyline and deprenyl, on mitochondrial integrity and apoptosis. Both pargyline and clorgyline are capable of protecting cells from apoptosis induced by serum starvation while deprenyl is ineffective. These data represent the first demonstration that MAO-A inhibitors may protect cells from apoptosis through a mechanism involving the maintenance of mitochondrial homeostasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598998     DOI: 10.1016/s0014-5793(98)00315-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Some new functions of amine oxidases.

Authors:  B Mondovì; P Pietrangeli; L Morpurgo; E Masini; R Federico; M A Mateescu; O Befani; E Agostinelli
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

2.  Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.

Authors:  Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

3.  Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Authors:  Glen B Baker; Bernard Sowa; Kathryn G Todd
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

Review 4.  Transcriptional regulation and multiple functions of MAO genes.

Authors:  Jean C Shih; Jason Boyang Wu; Kevin Chen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

5.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

6.  Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway.

Authors:  Xiao-Ming Ou; Kevin Chen; Jean C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-07       Impact factor: 11.205

7.  Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Authors:  Keiko Inaba-Hasegawa; Masayo Shamoto-Nagai; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2017-06-02       Impact factor: 3.575

8.  The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis.

Authors:  Shakevia Johnson; Shawna Tazik; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Junming Wang; Grazyna Rajkowska; Xiao-Ming Ou
Journal:  Front Neurosci       Date:  2010-11-02       Impact factor: 4.677

9.  Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.

Authors:  Shawna Tazik; Shakevia Johnson; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Craig A Stockmeier; Xiao-Ming Ou
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

10.  Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway.

Authors:  Nuria de Pedro; Bastien Cautain; Angeles Melguizo; Francisca Vicente; Olga Genilloud; Fernando Peláez; Jose R Tormo
Journal:  J Bioenerg Biomembr       Date:  2012-11-21       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.